Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis
Author(s): ,
Richard Moreau
Laboratoire d'Excellence (Labex) Inflamex, CUE Sorbonne Paris Cité, Paris, France
Thierry Gustot
The EASL-CLIF Consortium, European Foundation-CLIF, Barcelona, Spain
Corresponding author. Address: Director of the Liver Transplant Unit, Dept. of Gastroenterology and Hepato-Pancreatology, C.U.B. Erasme. 808 route de Lennik, 1070 Brussels, Belgium. Tel.: +3225553714; fax: +3225554802.
EASL LiverTree™. Gustot T. 12/01/18; 256748
Assoc. Prof. Thierry Gustot
Assoc. Prof. Thierry Gustot
Journal Abstract
This article does not have an abstract to display.Keyword(s)
Cirrhosis, Organ failure, Prognosis, Liver transplantation
[1]. G. D’Amico - New concepts on the clinical course and stratification of compensated and decompensated cirrhosis
[2]. V. Arvaniti - Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis
[3]. R. Jalan - Acute-on-chronic liver failure: pathophysiological basis of therapeutic options
[4]. S.K. Sarin - Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
[5]. R. Jalan - Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study
[6]. R.K. Dhiman - Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome
[7]. R. Moreau - Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
[8]. J.S. Bajaj - Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures
[9]. J.G. O’Leary - NACSELD Acute-on-Chronic Liver Failure (NACSELD-ACLF) Score Predicts 30-Day Survival in Hospitalized Patients with Cirrhosis
[10]. S. Piano - Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
[11]. T. Sersté - The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
[12]. Y. Shi - Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
[13]. H. Garg - Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure
[14]. A. Choudhury - Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models
[15]. J. Clària - Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure
[16]. M. Bernardi - Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis
[17]. H. Gomez - A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury
[18]. J.-M. Trawalé - The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
[19]. R. Moreau - The pathogenesis of ACLF: the inflammatory response and immune function
[20]. V. Arroyo - Acute-on-chronic liver failure in cirrhosis
[21]. R. Jalan - The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
[22]. T. Gustot - Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis
[23]. R. Jalan - Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
[24]. C.J. Karvellas - Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis
[25]. A.K. Choudhury - The decision for liver transplant in acute on chronic liver failure (ACLF) – first week is the crucial period – analysis of the APASL ACLF Research Consortium (AARC) prospective data of 1021 patients
[26]. M.K. Nadim - Management of the critically ill patient with cirrhosis: a multidisciplinary perspective
[27]. L.L. Gluud - Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
[28]. R. Bellomo - Intensity of continuous renal-replacement therapy in critically ill patients
[29]. J. Acevedo - Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death
[30]. J. Fernández - Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival
[31]. A. Putignano - New concepts in acute-on-chronic liver failure: implications for liver transplantation
[32]. S.W. Biggins - Futility and rationing in liver retransplantation: when and how can we say no?
[33]. F. Artru - Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3
[34]. B.-W. Duan - Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases
[35]. R. Bahirwani - Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes
[36]. R. Wiesner - Model for end-stage liver disease (MELD) and allocation of donor livers
[37]. W.R. Kim - Hyponatremia and mortality among patients on the liver-transplant waiting list
[38]. H.-Y. Sun - Impact of pretransplant infections on clinical outcomes of liver transplant recipients
[39]. K.-H. Lin - Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation
[40]. V.R. Bertuzzo - Impact of preoperative infection on outcome after liver transplantation
[41]. P. Mathurin - Early liver transplantation for severe alcoholic hepatitis
[42]. G.Y. Im - Early liver transplantation for severe alcoholic hepatitis in the United States–a single-center experience
[43]. M.K. Nadim - Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome
[44]. F. Wong - Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation
[45]. A.J. Slack - Ammonia clearance with haemofiltration in adults with liver disease
[46]. F.S. Cardoso - Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure
[47]. R. Bañares - Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial
[48]. A. Kribben - Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure
[49]. W. Yue-Meng - The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure
[50]. W. Mao - Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment
[51]. F.S. Larsen - High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial
[52]. V. Garg - Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure
[53]. X.-Z. Duan - Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure
[54]. M. Shi - Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients
[55]. B.-L. Lin - Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial
[56]. Y.-H. Li - Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study
[57]. C.A. Philips - Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies